Omega Flex, Inc. 2023 Q3 Form 10-Q Summary
Business context and reporting period
Omega Flex manufactures and sells flexible metal hose, gas piping, fittings, accessories, and corrugated medical tubing through distributors, wholesalers, sales representatives, and OEMs. The Company operates as one segment, with manufacturing facilities in Pennsylvania, Texas, and the United Kingdom. This unaudited report covers the three and nine months ended September 30, 2023, compared with the corresponding 2022 periods.
Financial performance and liquidity
| Metric | Q3 2023 | Q3 2022 | 9M 2023 | 9M 2022 |
|---|---|---|---|---|
| Net sales | $27.5 million | $31.6 million | $83.3 million | $94.7 million |
| Gross profit | $16.9 million | $19.8 million | $51.4 million | $59.7 million |
| Gross margin | 61.6% | 62.5% | 61.7% | 63.0% |
| Operating profit | $6.9 million | $8.6 million | $19.7 million | $23.3 million |
| Operating margin | 24.9% | 27.3% | 23.6% | 24.7% |
| Net income attributable to Omega Flex | $5.6 million | $6.5 million | $15.9 million | $17.4 million |
| Basic and diluted EPS | $0.55 | $0.65 | $1.57 | $1.73 |
For the nine months, operating cash flow was $11.5 million versus $4.6 million in 2022. Capital expenditures were $1.5 million, compared with $0.8 million, and dividends paid were $9.8 million, compared with $6.3 million. Cash increased modestly to $38.0 million from $37.7 million at December 31, 2022.
At September 30, 2023, accounts receivable were $16.2 million, inventories were $16.2 million, and total current assets were $74.8 million. Total liabilities were $18.4 million, compared with $26.5 million at year-end 2022. The Company had no borrowings outstanding under its unsecured $15.0 million revolving credit facility and was in compliance with its covenants. Management stated that cash and available borrowing capacity should meet anticipated needs for at least the next twelve months.
Material changes versus the prior comparable period
- Q3 sales declined 13.1%, and nine-month sales declined 12.0%, primarily because of lower unit volumes in a suppressed market and declining housing starts.
- Gross margin declined 90 basis points in Q3 and 130 basis points for the nine months. The primary causes were increased excess-inventory provisions for the new corrugated medical tubing products and lower production absorption of factory labor and overhead.
- Q3 operating profit declined 20.6%; nine-month operating profit declined 15.7%.
- General and administrative expense declined 15.1% in Q3 and 18.8% for the nine months, principally because prior-year product-liability provisions related to settled cases were lower in 2023.
- Interest income increased materially to $0.5 million in Q3 and $1.2 million for the nine months, primarily because of higher interest rates and the Company’s cash balance.
- Other liabilities declined by $3.6 million from year-end, mainly due to payments for legal and product-liability matters associated with two previously accrued cases.
- The Company declared quarterly dividends of $0.33 per share in September 2023, compared with $0.32 per share in September 2022. Total dividends declared for the first nine months were $9.9 million.
Guidance, outlook, risks, contingencies, and unusual items
The filing does not provide specific quantitative revenue, earnings, or margin guidance. Management expects existing cash and borrowing capacity to fund anticipated needs for at least the next twelve months, while future capital needs will depend on revenue growth, expansion, acquisitions, and capacity investments.
- The Company has pending product-liability claims, generally involving alleged lightning or electrical damage. Estimated aggregate maximum exposure within applicable insurance deductibles or retentions was approximately $4.6 million at September 30, 2023; recorded liabilities were $0.25 million. Management cannot estimate the ultimate liability.
- The Company has one significant customer representing more than 10% of accounts receivable and net sales, creating customer-concentration risk.
- Inventory reserves increased to $0.7 million from $0.6 million at year-end. An additional $0.75 million of long-term inventory, mainly materials for new CMT products, was expected to be used beyond the next twelve months.
- The revolving facility bears variable interest based on Term SOFR or the Prime Rate. Although there were no borrowings at quarter-end, future SOFR volatility could increase borrowing costs and affect liquidity.
- All leases are classified as operating leases. Lease liabilities totaled $2.9 million, including $0.45 million current, at September 30, 2023.
- Management reported effective disclosure controls and no material changes in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Whether housing and broader construction-market weakness continues to pressure unit volumes and revenue.
- Whether CMT product adoption supports utilization of existing inventory or leads to further inventory reserves.
- The status, settlement costs, and insurance coverage of pending product-liability claims.
- The sustainability of gross margins after lower production absorption and inventory provisions.
- Customer concentration and the effect of any change in the significant customer’s purchasing activity.
- Dividend capacity relative to operating cash flow, capital expenditures, and potential legal or expansion requirements.
- The terms and future borrowing costs under the renewed $15.0 million revolving credit facility.